BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it has received a ...
PALO ALTO, Calif., June 11, 2025--(BUSINESS WIRE)--Vivo Capital ("Vivo" or "we"), a leading global investment firm focused exclusively on healthcare and life sciences and an approximately 8% ...
Like you, we are shareholders in Sinovac Biotech Ltd. ("Sinovac" or the "Company"). Heng Ren Partners, LLC ("Heng Ren") manages funds that have held Sinovac shares since 2018. Heng Ren has long ...
The US Court of Appeals for the First Circuit has affirmed in full the dismissal of securities litigation against WilmerHale ...
Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: A medical worker holds a dose of the Sinovac vaccine at a district health facility as Indonesia begins mass ...
Sinovac Biotech Ltd. (NASDAQ: SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that SINOVAC has received on February 8, 2025 a formal court ...
Sinovac's COVID-19 vaccine was an estimated 98% effective at preventing death in Indonesian health workers. It was also 96% effective at preventing hospitalization, Indonesian officials said. The data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results